Want to see ATRO full AI Analyst Report?
Astronics (ATRO) AI Stock Analysis
Astronics
(NASDAQ:ATRO)
ATRO scores well on fundamental momentum and earnings-call outlook: profitability and cash flow have improved materially, and management raised revenue guidance with strong bookings/backlog supporting growth. Offsetting this are balance-sheet leverage risk and weak near-term technicals (below major moving averages with negative MACD), while valuation appears somewhat full at ~29x earnings with no dividend support.
Astronics Key Performance Indicators (KPIs)
Revenue by SegmentBreaks down income from various business units, providing insight into which segments drive growth and how diversified the company’s revenue sources are.
Aerospace is clearly the growth engine—steady, accelerating quarters drove the record revenue and are the main source of margin expansion management highlighted—while Test Systems is lumpy and still under‑absorbed, with recent profit improvement tied to restructuring but dependent on the U.S. Army 4549T program ramp for sustainable gains. Management’s 2026 guidance assumes continued Aerospace momentum; watch Test Systems’ program timing plus elevated capex/ERP and tariff/net‑debt pressures as the key execution risks to near‑term cash and margins.
Astronics (ATRO) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $2.08B
- Dividend Yield
- ―
- Average Volume (3M)
- 604.46K
- Price to Earnings (P/E)
- 28.2
- Beta (1Y)
- 0.93
- Revenue Growth
- 14.49%
- EPS Growth
- ―
- Country
- US
- Employees
- 2,700
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Aerospace & Defense
Astronics Business Overview & Revenue Model
Company Description
Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace, defense, and electronics industries in the United States, rest of North America, Asia, Europe, South America, and internationally. It operates in tw...
How the Company Makes Money
Astronics makes money primarily by selling engineered aerospace components, subsystems, and test equipment to aircraft and avionics manufacturers and, in many cases, continuing to earn revenue over the life of an aircraft platform through aftermarket...
Astronics Earnings Call Summary
The call conveyed strong operational and financial momentum — record revenue, bookings, backlog and materially improved margins (adjusted EBITDA ~19.8%), supported by major program wins (MV-75 development and a $44.7M Army production order), improving cash generation and a healthier balance sheet. Headwinds exist (ongoing tariff costs, temporary margin pressure in Test Systems during ramp, GEO disruption from LEO transition, and remaining contract repricing work), but management presented clear levers (volume, pricing, efficiency, portfolio simplification) with room to run. On balance, the positives substantially outweigh the negatives.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management raised FY2026 revenue guidance to $1.02–$1.04 billion and expects Q3 sales of $265–$275 million with Q4 revenue modestly higher, targeting adjusted operating/EBITDA margins in the high teens (Q2 adjusted EBITDA margin = 19.8%, adjusted operating margin = 16.6%); they forecast ~$35 million of 2026 revenue from the MV‑75 FLRAA program, expect the $44.7M Army 4549 radio test production award to ramp to full‑rate by the end of Q4 (supporting ~18 months of deliveries) and to drive Test margins closer to Aerospace levels, and noted Q2 bookings of $306M with Aerospace bookings $243.1M (book‑to‑bill 1.02) and Test bookings $63.1M (book‑to‑bill 2.78) leaving backlogs of $657.2M (Aerospace) and $123.3M (Test); other guidance items include R&D of roughly $10–$12M per quarter, full‑year CapEx of $40–$45M (YTD $16.9M), expected future IEEPA tariff refunds of ~$6–$8M (timing uncertain) offset by an ongoing tariff run‑rate of ~$3–$4M/quarter, an expectation to be free‑cash‑flow positive for the remainder of the year, available liquidity of $253.2M and long‑term debt of $310.3M, and potential additional deferred tax valuation allowance release of roughly $40–$50M pending sufficient future taxable income.
Astronics Financial Statement Overview
Summary
Financials show a strong turnaround with meaningful revenue growth and sharply improved margins, plus a shift to consistently positive operating and free cash flow. The main constraint is elevated leverage (debt still high relative to equity), which reduces flexibility if demand or margins soften.
Income Statement
76PositiveBalance Sheet
58NeutralCash Flow
72Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 942.09M | 862.13M | 795.43M | 689.21M | 534.89M | 444.91M |
| Gross Profit | 306.51M | 258.16M | 168.34M | 120.80M | 71.54M | 65.36M |
| EBITDA | 116.65M | 66.34M | 16.60M | -207.00K | -2.02M | -4.68M |
| Net Income | 79.12M | 29.36M | -16.21M | -26.42M | -35.75M | -25.58M |
Balance Sheet | ||||||
| Total Assets | 760.84M | 706.68M | 648.76M | 649.00M | 615.03M | 609.14M |
| Cash, Cash Equivalents and Short-Term Investments | 9.02M | 18.18M | 9.29M | 11.31M | 13.78M | 29.76M |
| Total Debt | 352.97M | 378.35M | 193.87M | 197.88M | 178.41M | 181.80M |
| Total Liabilities | 562.62M | 566.60M | 392.67M | 399.48M | 375.11M | 352.53M |
| Stockholders Equity | 198.22M | 140.07M | 256.10M | 249.52M | 239.92M | 256.60M |
Cash Flow | ||||||
| Free Cash Flow | 61.42M | 43.12M | 22.14M | -31.59M | -35.99M | -11.56M |
| Operating Cash Flow | 103.25M | 74.80M | 30.57M | -23.95M | -28.31M | -5.53M |
| Investing Cash Flow | -63.91M | -53.75M | -8.43M | -4.11M | 14.39M | 3.18M |
| Financing Cash Flow | -43.25M | -22.39M | -14.53M | 25.43M | -1.41M | -7.50M |
Astronics Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATRO, the sentiment is Negative. The current price of 57.48 is below the 20-day moving average (MA) of 61.15, below the 50-day MA of 66.92, and below the 200-day MA of 66.20, indicating a bearish trend. The MACD of -2.16 indicates Negative momentum. The RSI at 36.46 is Neutral, neither overbought nor oversold. The STOCH value of 41.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATRO.
Astronics Risk Analysis
Astronics disclosed 42 risk factors in its most recent earnings report. Astronics reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksAstronics Peers Comparison
Overall Rating
MOG.A80Outperform
WWD71Outperform
ATRO68Neutral
CW66Neutral
MRCY59Neutral
DCO55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | $11.45B | 27.36 | 18.00% | 0.37% | 15.65% | 78.52% | |
| 71Outperform | $19.64B | 35.28 | 21.75% | 0.38% | 22.35% | 41.77% | |
| 68Neutral | $2.62B | 28.18 | 51.97% | ― | 14.49% | ― | |
| 66Neutral | $18.38B | 30.95 | 20.69% | 0.22% | 10.54% | 22.56% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 59Neutral | $4.89B | -142.16 | -2.01% | ― | 7.85% | 22.99% | |
| 55Neutral | $2.52B | -86.37 | -3.72% | ― | 8.57% | -162.23% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ATRO | Astronics | 57.48 | 19.97 | 53.24% | |
| CW | Curtiss-Wright Corp | 452.13 | -122.90 | -21.37% | |
| DCO | Ducommun Incorporated | 156.33 | 67.18 | 75.36% | |
| MRCY | Mercury Systems | 71.76 | -3.60 | -4.78% | |
| MOG.A | Moog Inc. | 325.81 | 126.64 | 63.58% | |
| WWD | Woodward | 326.37 | 63.24 | 24.03% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 21, 2026